INSULET CORPORATION Derivative Asset
INSULET CORPORATION (PODD) had Derivative Asset of $1.00 million as of 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-02-18
- 2025-12-31: Derivative Asset $1.00M.
- 2024-12-31: Derivative Asset $5.40M.
| Period end | Derivative Asset |
|---|---|
| 2025-12-31 | $1.00M 10-K · filed 2026-02-18 |
| 2024-12-31 | $5.40M 10-K · filed 2026-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |